Does zonulin signaling increase intestinal permeability?

Zonulin acts as a primary physiological regulator of intercellular tight junctions, and its signaling pathway has been heavily investigated in the context of barrier dysfunction and inflammatory diseases.

Cellular mechanisms of zonulin signaling

• Zonulin (pre-haptoglobin-2) binds to the apical surface of intestinal epithelial cells, initiating a cascade that transactivates epidermal growth factor receptor (EGFR) via protease-activated receptor-2 (PAR2).
• This dual activation triggers phospholipase C, raising intracellular calcium and diacylglycerol, which activates protein kinase C-alpha (PKC-α).
• Activated PKC-α phosphorylates key tight junction proteins—specifically zonula occludens-1 (ZO-1) and occludin—causing them to detach from the actin cytoskeleton and redistribute laterally away from the junctional complex.
• The physical disassembly and loosening of these tight junctions open the paracellular space, directly leading to increased intestinal permeability (characterized by decreased transepithelial electrical resistance and increased macromolecular flux).

Diagnostic utility of fecal zonulin-family peptides

• Commercial stool tests measure a heterogeneous group of "zonulin-family peptides" (ZFPs), which often include cross-reacting proteins like properdin, rather than pure pre-haptoglobin-2.
• These stool ZFP levels show weak and inconsistent quantitative correlations with gold-standard functional intestinal permeability measurements, such as the lactulose-mannitol (LM) ratio.
• This discrepancy occurs because the LM ratio specifically measures small-intestinal paracellular flux, whereas stool ZFPs reflect luminal release along the entire gastrointestinal tract, influenced by local microbiota, transit times, and mucosal immune activity.
• Elevated fecal ZFPs remain clinically relevant as plausible, non-invasive biomarkers of mucosal barrier stress, strongly correlating with markers of active intestinal inflammation like fecal calprotectin in conditions such as pediatric inflammatory bowel disease (IBD).

Bottom line

• Zonulin signaling directly increases intestinal permeability by loosening epithelial tight junctions through a highly regulated PAR2/EGFR/PKC-α signaling pathway. However, while elevated stool zonulin-family peptides are associated with mucosal inflammation, they do not consistently correlate with functional, gold-standard tests of intestinal permeability due to assay cross-reactivity and physiological differences in what is being measured.